Global Hyaluronic Acid for Osteoarthritis Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hyaluronic Acid for Osteoarthritis Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Hyaluronan is a natural substance found in the body and is present in very high amounts in joints. The body’s own hyaluronan acts like a lubricant and a shock absorber in the joint and is needed for the joint to work properly. Hyaluronic acid is similar to a substance that occurs naturally in the joints. It works by acting like a lubricant and shock absorber in the joints and helps the joints to work properly.
Hyaluronic Acid for Osteoarthritis report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hyaluronic Acid for Osteoarthritis market is projected to reach US$ 806.5 million in 2029, increasing from US$ 541 million in 2022, with the CAGR of 6.3% during the period of 2024 to 2029. Demand from Knee Joint and Hip Joint are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hyaluronic Acid for Osteoarthritis industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Hyaluronic Acid for Osteoarthritis key manufacturers include BIOVENTUS, Sanofi, Ferring B.V., Anika Therapeutics, Fidia Farma, LG Chem, Bohus BioTech, Hangzhou Singclean Medical Products and Biolevox, etc. BIOVENTUS, Sanofi, Ferring B.V. are top 3 players and held % sales share in total in 2022.
Hyaluronic Acid for Osteoarthritis can be divided into Single-Phase and Duplex, etc. Single-Phase is the mainstream product in the market, accounting for % sales share globally in 2022.
Hyaluronic Acid for Osteoarthritis is widely used in various fields, such as Knee Joint, Hip Joint, Shoulder Joint and Ankle Joint, etc. Knee Joint provides greatest supports to the Hyaluronic Acid for Osteoarthritis industry development. In 2022, global % sales of Hyaluronic Acid for Osteoarthritis went into Knee Joint filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hyaluronic Acid for Osteoarthritis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
BIOVENTUS
Sanofi
Ferring B.V.
Anika Therapeutics
Fidia Farma
LG Chem
Bohus BioTech
Hangzhou Singclean Medical Products
Biolevox
Vivacy
ideolab
Xediton Pharmaceuticals
Deka
BIOIBERICA
Segment by Type
Single-Phase
Duplex
Knee Joint
Hip Joint
Shoulder Joint
Ankle Joint
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hyaluronic Acid for Osteoarthritis market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hyaluronic Acid for Osteoarthritis, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hyaluronic Acid for Osteoarthritis industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hyaluronic Acid for Osteoarthritis in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hyaluronic Acid for Osteoarthritis introduction, etc. Hyaluronic Acid for Osteoarthritis Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Hyaluronic Acid for Osteoarthritis market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Hyaluronic Acid for Osteoarthritis report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hyaluronic Acid for Osteoarthritis market is projected to reach US$ 806.5 million in 2029, increasing from US$ 541 million in 2022, with the CAGR of 6.3% during the period of 2024 to 2029. Demand from Knee Joint and Hip Joint are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hyaluronic Acid for Osteoarthritis industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Hyaluronic Acid for Osteoarthritis key manufacturers include BIOVENTUS, Sanofi, Ferring B.V., Anika Therapeutics, Fidia Farma, LG Chem, Bohus BioTech, Hangzhou Singclean Medical Products and Biolevox, etc. BIOVENTUS, Sanofi, Ferring B.V. are top 3 players and held % sales share in total in 2022.
Hyaluronic Acid for Osteoarthritis can be divided into Single-Phase and Duplex, etc. Single-Phase is the mainstream product in the market, accounting for % sales share globally in 2022.
Hyaluronic Acid for Osteoarthritis is widely used in various fields, such as Knee Joint, Hip Joint, Shoulder Joint and Ankle Joint, etc. Knee Joint provides greatest supports to the Hyaluronic Acid for Osteoarthritis industry development. In 2022, global % sales of Hyaluronic Acid for Osteoarthritis went into Knee Joint filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hyaluronic Acid for Osteoarthritis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
BIOVENTUS
Sanofi
Ferring B.V.
Anika Therapeutics
Fidia Farma
LG Chem
Bohus BioTech
Hangzhou Singclean Medical Products
Biolevox
Vivacy
ideolab
Xediton Pharmaceuticals
Deka
BIOIBERICA
Segment by Type
Single-Phase
Duplex
Segment by Application
Knee Joint
Hip Joint
Shoulder Joint
Ankle Joint
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hyaluronic Acid for Osteoarthritis market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hyaluronic Acid for Osteoarthritis, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hyaluronic Acid for Osteoarthritis industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hyaluronic Acid for Osteoarthritis in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hyaluronic Acid for Osteoarthritis introduction, etc. Hyaluronic Acid for Osteoarthritis Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Hyaluronic Acid for Osteoarthritis market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices